Covid-19 Vaccine to be Distributed on 14 September to all Russian Regions

The first load of the vaccine against the sputnik vaccine COVID-19 is scheduled to be shipped to the regions of the world on Monday 14 September, developed by the Russian Gamaleya National Research Center for Epidemiology and microbiology and the Russian Direct Investment Fund (RDIF). Russian health minister Mikhail Murashko announced on a Live Mint broadcast that the first samples of the supply chain-test vaccine have already delivered and the government is now testing the supply chain. The area in Leningrad has been supplied with [the vaccine] as well as the first ones and by Monday (14 Sept) first samples of the vaccine are to be supplied, “Mikhail Murashko said.

A study by Denis Logunov, deputy director for research of the institute, associate member of the Russian Academy of Sciences, said earlier: “Sputnik V Covid vaccines, which are produced by the Gamaleya Institute of Epidemiology and Microbiology under the Russian Ministry of Health, may be granted release permission of a batch of his civilian use vaccine. A Phase III experiment includes thousands of people-40,000 people in Russia-for a long time. The Interfax news agency announced on Friday that over one billion people were going to get their COVID-19 vaccine “Sputnik-V” in 2020-21. Meanwhile, after classes online, Russian children returned to schools after the corona viral pandemic hit the world at the end of March.

On 11 August the first COVID-19 vaccine, known as Sputnik V, was reported by the Russian Ministry of Health. Sputnik V vaccine consists of two shots that have been designed by manufacturers to bear the surface protein or spike gene for SARS-CoV-2 inducing COVID-19, with various types of adenoviruses, both of which are triggering a common cold. According to previous findings in The Lancet Medical Journal, which were lauded by Moscow to counter opponents, this vaccine developed an antibody response for all those interested in early-stage studies. The findings of the two trials, performed in June-July of this year with 76 volunteers, showed that 100% of volunteers developed new coronavirus antibodies and had no significant negative effects, said The Lancet. However, the findings of Lancet Medical Journal were criticized by a panel of foreign science analysts, who claimed that certain findings seemed doubtful. Amid the possible vaccine data, the Russian Coronavirus Response Centre said on Sunday, had reported 5,449 COVID-19 in the last 24 hour taking the overall number to 1,062,811.

For more latest news Click Here

Follow Us
Twitter: @TimesTechPharm1

Leave a Reply

Your email address will not be published. Required fields are marked *